ELISA CDR2 anti-

Quantity :50µL Clone Number: Aliases:AA617262 antibody; CDR 2 antibody; CDR 62 antibody; CDR2 antibody; CDR2_ antibody; CDR62 antibody; Cerebellar degeneration related protein 2 62kDa antibody; Cerebellar degeneration related protein 2 antibody; Cerebellar degeneration related protein antibody; Cerebellar degeneration-related protein 2 antibody; Major Yo paraneoplastic antigen antibody; MGC116181 antibody; MGC144810 antibody; MGC144811 antibody; Paraneoplastic cerebellar degeneration associated antigen antibody; Paraneoplastic cerebellar degeneration-associated antigen antibody; PCD 17 antibody; PCD17 antibody; RGD1310578 antibody; Yo antibody; Yo paraneoplastic antigen antibody Product Type:Polyclonal Antibody Immunogen Species:Homo sapiens () UniProt ID:Q01850 Immunogen:Fusion protein of CDR2 Raised in:Rabbit Reactivity:, Mouse Tested Applications:ELISA, IHC; ELISA:1:1000-1:2000, IHC:1:25-1:100 Background:CDR2 (cerebellar degeneration-related protein 2), also referred to as Yo or CDR62, is a 545 amino acid protein that is associated with the development of paraneoplastic cerebellar degeneration (PCD). PCD, an immune-mediated syndrome, belongs to a heterogeneous group of rare paraneoplastic neurologic disorders affecting the neurological system. PCD is characterized by subacute cerebellar ataxia and occurs mainly in patients with ovarian, uterine, fallopian tube or breast cancer. Clonality:Polyclonal Isotype:IgG Purification Method:Antigen affinity purification Conjµgate:Non-conjµgated Buffer:-20°C, pH7.4 PBS, 0.05% NaN3, 40% Glycerol Form:Liquid Stroage:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Target Names:CDR2 Research Areas:Cancer;Immunology